Alka Chaubey - Feb 15, 2024 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Jonathan V. Dixon, Attorney-in-Fact
Stock symbol
BNGO
Transactions as of
Feb 15, 2024
Transactions value $
-$1,373
Form type
4
Date filed
3/5/2024, 05:48 PM
Previous filing
Sep 20, 2023
Next filing
Jun 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNGO Common Stock Tax liability -$1.37K -1.08K -3.32% $1.27 31.5K Feb 15, 2024 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is reporting the withholding by the Issuer of an aggregate of 1,081 shares of common stock in connection with shares that vested on February 15, 2024 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award.
F2 On August 4, 2023, the common stock of Bionano Genomics, Inc. split 1-for-10, resulting in the reporting person's ownership of 112,315 less shares of common stock.
F3 Includes 89 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan on June 12, 2023.